Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
- Published In:
- Bioorganic & medicinal chemistry, 21(17), 5004-11 (2013)
- Database ID:
- RPEP-02163
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02163APA
Elsawy, Mohamed A; Martin, Lorraine; Tikhonova, Irina G; Walker, Brian. (2013). Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.. Bioorganic & medicinal chemistry, 21(17), 5004-11. https://doi.org/10.1016/j.bmc.2013.06.055
MLA
Elsawy, Mohamed A, et al. "Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.." Bioorganic & medicinal chemistry, 2013. https://doi.org/10.1016/j.bmc.2013.06.055
RethinkPeptides
RethinkPeptides Research Database. "Solid phase synthesis of Smac/DIABLO-derived peptides using ..." RPEP-02163. Retrieved from https://rethinkpeptides.com/research/elsawy-2013-solid-phase-synthesis-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.